BioE graduate students capture top prizes at the Pitt Three Minute Thesis competition

Bioengineering, Student Profiles

PITTSBURGH (April 16, 2019) … After their success in the Swanson School of Engineering’s Three Minute Thesis (3MT) competition, bioengineering graduate students Piyusha Gade and Gerald Ferrer participated in the university-wide event hosted by the University of Pittsburgh Office of the Provost on April 1, 2019. Gade was awarded first place while Ferrer captured the runner-up prize and the People’s Choice award. The Pitt 3MT competition was held during National Graduate and Professional Student Appreciation Week, a celebration to emphasize the contributions, impact, and value of graduate and professional students on campuses throughout the United States. The Provost’s Office presented four prizes for the 3MT competition: first place was awarded a $1000 travel grant, two runner-ups were each awarded a $500 travel grant, and for the first time at Pitt, a $1000 travel grant was awarded to a People’s Choice winner. “I am proud that both Piyusha and Gerald received awards at the university-wide Three Minute Thesis competition,” said Mary Besterfield-Sacre, Nickolas A. Dececco Professor of Industrial Engineering and Associate Dean for Academic Affairs. “We try to prepare our Swanson School students for successful careers in STEM, and effective communication is an important but often overlooked part of that.” Gade, who placed first in both the Pitt and Swanson School 3MT competition, is a bioengineering a graduate student in the lab of Dr. Anne Robertson, Professor of Mechanical Engineering and Materials Science. She presented her research which involves rationally designing in situ engineered vascular grafts in young and aged hosts. “Piyusha is an outstanding researcher – extremely smart, innovative and versatile,” Robertson said. “She is always ready to take on new challenges, both intellectually and professionally. I am so proud of Piyusha and her accomplishment!” Ferrer, who was a runner-up in the Swanson School competition, presented his work from the Orthopaedic Robotics Lab of Dr. Richard Debski, professor of bioengineering. His current research is focused on quantifying location specific mechanical properties in tendons using different ultrasound techniques and understanding key biomechanical factors that influence rotator cuff tear propagation through computational models. "I enjoyed the challenge of communicating the significance and impact of our research in a way that everyone - regardless of their background - could understand and relate to, all in under 3 minutes,” Ferrer said. “Being able to communicate with a diverse audience is important because it allows us to bridge the gap between scientists and nonscientists thus increasing awareness of the societal impact of your research.” The 3MT Competition, developed by The University of Queensland, is designed to encourage students to communicate the importance of their research to the broader community. Since its launch in 2008, the 3MT competition has expanded to 67 countries, and events are currently held at more than 600 universities worldwide. ###

Maria Jantz Receives the 2019 National Defense Science and Engineering Graduate Fellowship Award

Bioengineering, Student Profiles

PITTSBURGH (April 9, 2019) … Maria Jantz, a bioengineering graduate student at the University of Pittsburgh Swanson School of Engineering, was selected to receive the 2019 National Defense Science and Engineering Graduate (NDSEG) Fellowship Award. The competitive fellowship, which received more than 2,900 applications, recognizes academic excellence in STEM fields and awards up to three years of full tuition, a monthly stipend, health insurance, and a travel budget for research-related training and/or conferences. Jantz received her undergraduate degree in physics at Goshen College, where she developed an interest in prostheses. Following college, she worked with Professors Lee Miller and Matthew Tresch at Northwestern University to use functional electrical stimulation to restore locomotion following spinal cord injuries. She has continued to explore these interests at Pitt and joined the lab of Robert Gaunt, assistant professor of physical medicine and rehabilitation, where she studies epidural stimulation of the spinal cord to improve bladder control. “After spinal cord injuries, bladder control is one of the most important functions people want to have restored,” said Jantz. “By applying electrical stimulation to the surface of the spinal cord, we can activate nerves in that region to produce bladder reflexes that improve continence and voiding. “Spinal cord stimulation is a really exciting area of research with a lot of possibilities that we are only now figuring out, and I'm very happy to be a part of that,” Jantz continued. “With an application in bladder control, specifically, I get to improve an issue that many people deal with daily that regularly goes unaddressed, and I think it's really important to meet that need.” In 2018 Jantz was awarded an honorable mention from the National Science Foundation Graduate Research Fellowship Program and was the recipient of the best oral presentation award from the Society for Pelvic Research. “I feel very fortunate to have Maria working in my lab on a problem that is such a significant issue for so many people,” said Gaunt. “This award recognizes Maria’s outstanding talents and abilities, and I’m really looking forward to see what she is able to accomplish with this generous support!” ###

Bioengineering’s Role in Regenerative Medicine

Bioengineering

Starfish can repair injured arms and reptiles can regrow severed tails; from bacteria to humans, every species is capable of regeneration, albeit to variable extents. These functions help make species more resilient, but how can we apply the knowledge of these regenerative mechanisms to improve human health? The University of Pittsburgh Department of Bioengineering has been collaboratively working to address this question through research efforts in tissue engineering and regenerative medicine. In 1981, upon the arrival of Dr. Thomas E. Starzl at the University of Pittsburgh Medical Center, Pittsburgh quickly became world-renowned in transplantation. This helped put Pittsburgh on the map in the medical community, eventually leading to increased interest in artificial organs and the establishment of the McGowan Center for Artificial Organ Development in 1992. This Center, which later became the McGowan Institute for Regenerative Medicine, continues to flourish and develop therapies that reestablish tissue and organ function impaired by disease, trauma, or congenital abnormalities. The McGowan Institute of Regenerative Medicine (MIRM) received its current title in 2001 when the Center's mission was expanded to include tissue engineering, adult-derived stem cell and wound healing research, and several other areas of investigation. “We could have carried on with medical device and artificial organ research, but we recognized that we wanted to address the problem – organ and tissue failure – and begin to develop a wider range of technologies,” said William R. Wagner, PhD, director of MIRM and professor of surgery at Pitt. Dr. Wagner, who joined the University in 1991, saw his own research begin to evolve beyond artificial organs. He studied blood coagulation from an engineering perspective, which turned out to be useful in understanding why artificial hearts were forming blood clots, but he later wanted to move beyond artificial hearts and look at ways to make tissue for cardiac repair. His research group currently focuses on developing cardiovascular technologies, with projects that address medical device biocompatibility and design, hypothesis-driven biomaterials development, tissue engineering, and targeted imaging. Dr. Wagner believes that advancements in regenerative medicine require a collaborative effort in which bioengineering plays a large role. “An interdisciplinary approach is what makes the McGowan Institute thrive,” he said. “The problem we are trying to solve is what happens when a part of the body is no longer working. A clinical viewpoint is necessary, but medical training doesn’t give you an engineer’s perspective of design and manufacturing. You need a solid foot in both camps to make progress.” This approach is well-suited for the University of Pittsburgh, which ranked fourth among U.S. universities in funding by the National Institutes of Health in FY 2018. These research opportunities are complemented by the world-renowned University of Pittsburgh Medical Center, which has helped to create a collaborative environment conducive to productive medical research. “Institutes are created to bring people from different disciplines together to solve a common problem, and that is exactly what we are doing at the McGowan Institute,” said Dr. Wagner. “If you look in our laboratories, you could find a nursing professor, a pathology professor, a cardiac surgeon, or a bioengineer – it is a very diverse population. We have a wide range of research, and this center allows these collaborations to be built and supported.” Among this wide range of researchers are 16 primary bioengineering faculty. From the design and development of novel artificial lung devices to the creation of an injectable gel technology that helps injured peripheral nerves repair and regenerate, bioengineering faculty have made an impact on biomedical translational research and innovation at Pitt. “I think we are at a very exciting point where the commercialization of a lot of our inventions is not only possible but practical,” said Wagner. “Our ideas and the technology we have developed are more mature, and the investment community has a better idea of what we are trying to do.” The translational research efforts at MIRM have led to 30 spinout companies derived from MIRM-affiliated faculty. Bioengineering has contributed to the success of these efforts by offering the Center for Medical Innovation, which provides early-stage seed grants to projects, and the Coulter Translational Research Partners II Program, which provides funding and helps lead the projects to commercialization. Beyond research, education is another priority of the McGowan Institute. Part of their mission is to educate and train scientists and engineers to pursue technologies related to regenerative medicine and train a generation of clinicians in the implementation of regenerative therapies. Bioengineering makes up a large part of MIRM graduate student population, which also includes surgical fellows and residents. MIRM-associated faculty currently participate in three NIH training grants to support the educational efforts: the Biomechanics in Regenerative Medicine (BiRM) program, the Cardiovascular Bioengineering Training Program (CBTP), and the Cellular Approaches to Tissue Engineering and Regeneration (CATER) program. In addition, MIRM serves local, national, and international undergraduate students through the Regenerative Medicine Summer School, a hands-on experiential learning program launched by Bioengineering Assistant Professor Bryan Brown, which aims to recruit students from underrepresented backgrounds, including those at universities without significant bioengineering and/or regenerative medicine programs. This educational program nicely complements the CampBioE effort by the Department of Bioengineering, which is a tissue engineering summer camp for middle and high school students. “I consider MIRM to be a scaffold that brings together individuals interested in tissue engineering and regenerative medicine and facilitates their interactions,” said Sanjeev Shroff, Distinguished Professor and Gerald E. McGinnis Chair of Bioengineering. “The symbiotic relationship between MIRM and the Department of Bioengineering greatly benefits our students and faculty, offering outstanding opportunities for training and research collaborations.” All of these efforts have led the McGowan Institute of Regenerative Medicine to be one of the most prominent institutes of its kind. As this dynamic field evolves and grows, the Department of Bioengineering will continue to contribute to the diverse group of researchers at MIRM who pursue the development of innovative technology and new therapies for patients in need. ###

Allderdice Senior Caroline Yu to Present Research at IEEE International Conference on Biomedical and Health Informatics

All SSoE News, Bioengineering, Electrical & Computer

PITTSBURGH (April 3, 2019) — High school students in the Pittsburgh area get the chance to work with groundbreaking researchers—and, sometimes, even become published authors before high school graduation. Caroline Yu, a senior at Taylor Allderdice High School in Squirrel Hill, worked in Ervin Sejdic’s iMed Lab through the University of Pittsburgh Computer Science, Biology and Biomedical Informatics (CoSBBI) program. Working closely PhD candidate Yassin Khalifa, Miss Yu co-authored a paper titled “Silent Aspiration Detection in High Resolution Cervical Auscultations,” which has been accepted at the IEEE International Conference on Biomedical and Health Informatics. The authors will present their findings at the Dorin Forum at the University of Illinois at Chicago, held May 19-22, 2019. The CoSBBI program is part of the UPMC Hillman Cancer Center Academy. This UPMC partnership invites high school students to work on an authentic cancer research project while receiving mentorship and training. “Caroline did an amazing job, and I’m proud and excited to see her success in her first publication,” says Dr. Sejdic, associate professor of electrical and computer engineering at Pitt’s Swanson School of Engineering. “We know she is headed for great things.” After graduation, Miss Yu says that while she is still waiting to hear back from a few schools before making her final decision, she plans to major in computer science.
Maggie Pavlick

MEMS Undergraduate Trevor Kickliter Selected to Represent Pitt at the ACC Meeting of the Minds

Bioengineering, MEMS, Student Profiles

PITTSBURGH (March 27, 2019) … Trevor Kickliter, a junior mechanical engineering student in the Swanson School of Engineering, was selected as one of six undergraduate researchers to represent the University of Pittsburgh at the 2019 ACC Meeting of the Minds Conference hosted by the University of Louisville, March 29-31, 2019. Kickliter will present his research on the use of adipose-derived mesenchymal stem cells (ADMSCs) as a promising alternative to traditional surgical therapy for an abdominal aortic aneurysm (AAA). With a mortality rate of 90 percent and no sufficient strategy for early intervention, rupture of an abdominal aortic aneurysm is one of the leading causes of death in the United States. The aorta is the largest blood vessel in the body, which runs from the heart, through the chest, and down to the abdomen. Due to its size, an AAA can lead to massive internal bleeding, which is typically fatal. According to Kickliter, due to inadequate diagnostic markers, surgical intervention for this disease often fails to treat those in need of care while subjecting others to unnecessary risks. His work in the lab of David Vorp, PhD, Associate Dean for Research and the John A. Swanson Professor of Bioengineering, addresses these shortcomings through the use of stem cell therapy. “Our lab has previously investigated the use of adipose-derived mesenchymal stem cells in therapies for abdominal aortic aneurysm, but a method to effectively target ADMSCs to the aorta has yet to be developed or tested in large animals,” said Kickliter. “Since the use of ADMSCs as a therapeutic treatment seems promising, the primary goal of this study was to design and create a method for localizing ADMSCs in large animal aortas.” The group implanted a diametric magnet into a harvested aorta loaded with ADMSCs that were treated with iron nanoparticles. The internal magnet was then able to draw the ADMSCs to the aortic adventitia - the outermost layer of connective tissue in the aorta. “We looked at a cross-section of the treated aorta under fluorescent microscopy, and we found a significantly greater concentration of ADMSCs both on and around the aortic adventitia in the group where an internal magnet was used,” said Kickliter. “These results suggest that our method can be used to localize stem cell-based vascular therapies in other large animals, including humans.” Each participating institution in the ACC Meeting of the Minds conference is allowed to select a total of six students to give three oral presentations and three poster presentations. Kickliter will present his research during the poster session. “This is another outstanding recognition for Trevor, who continues to impress me with the quality of his research,” said Dr. Vorp. “This work introduces a novel way to localize delivery of stem cell therapy in large animals, and we hope that it will lead to improved treatment for abdominal aortic aneurysms.” ###

Bioengineering undergraduates take their diagnostic innovation to the Rice 360° Global Health Competition

Bioengineering, Student Profiles

PITTSBURGH (March 22, 2019) … Two junior bioengineering students from the University of Pittsburgh were accepted to the Rice 360° Global Health Design Competition where more than 20 national and international student teams will present low-cost global health innovations. Sneha Jeevan and Shivani Tuli will be representing Pitt’s Swanson School of Engineering at the competition in Houston, Texas on March 29, 2019. They will demonstrate their handheld complete blood count (CBC) point-of-care device, which can be used as a diagnostic tool for doctors working in underdeveloped nations. The competition asks teams to identify a challenge in delivering healthcare in developing countries and propose a potential technological solution. Tuli was inspired to create this device after a visit to India where she had the opportunity to travel to underprivileged areas and witness healthcare problems first-hand. “Disparities in healthcare access and quality can greatly affect the health of residents in third world countries,” said Tuli. “Diseases like malaria and tuberculosis are rampant, and the lack of quality healthcare prevents proper treatment and contributes to further spread of disease. In developed areas, these illnesses are typically diagnosed through primary blood tests, specifically complete blood count testing, so we wanted to create a tool to help make this technology widespread.” Their team, Blodot, used lab-on-a-chip technology and microfluidic concepts to develop a prototype CBC point-of-care device. Their portable technology uses a drop of blood and receives results within a few minutes. “A CBC test checks several measurable components of your blood in order to detect possible diseases and assess overall health,” said Jeevan. “In underdeveloped countries, however, CBC testing cannot be easily implemented because the machinery involved is expensive and unsuitable for the unhygienic conditions. Additionally, the time it takes for families to receive their results - typically two-to-four days - is impractical for residents who need to travel hours for their appointments with a physician.” According to the competition, teams will be judged on “the quality of the problem definition, the effectiveness and potential impact of the design solution, and the likelihood that the solution can be successful in improving healthcare delivery in low-resource settings by faculty, clinicians, and private and public sector partners from around the country.” “It is an absolute delight to see our undergraduates take advantage of such initiatives to become innovators of the future,” said Arash Mahboobin, assistant professor of bioengineering and coordinator of the undergraduate program. “I have known Shivani and Sneha since the start of their engineering endeavors in the Swanson School and am very proud of their achievements thus far. I will certainly continue to watch their careers develop with great interest and high expectations.” Tuli and Jeevan recently participated in the final round of the Innovation Institute’s Randall Family Big Idea Competition, an event that awards $100,000 in cash prizes to Pitt student innovations with the goal of helping teams discover how to take their idea to the next level towards startup creation. Blodot placed second in the competition and won a $15,000 prize. ###

Bistra Iordanova receives a $25K award to address the differences between men and women in Alzheimer’s disease risk and progression

Bioengineering

PITTSBURGH (March 21, 2019) Alzheimer's disease (AD) is one of the leading causes of disability in the elderly, affecting 5.4 million people in the United States and 35 million people worldwide.1 Two-thirds these individuals are women, and though they are disproportionately affected, the biological basis of the sex differences in AD onset and progression is not well understood. Bistra Iordanova, assistant professor of bioengineering at the University of Pittsburgh, received a $25,000 award from the Alzheimer’s Disease Research Center to collect data from female rodent models, integrate it with her existing datasets from males, and begin to examine whether AD onset and progression differs between the two. One reason AD research lacks female data is because in a significant portion of human studies, the sex variable is regressed out, and the data are pooled together. And until recently, the bulk of animal studies exclusively used males in an effort to keep costs low. “A long-held view for the cause of the disparity between men and women developing Alzheimer’s disease pointed at the greater female lifespan,” said Dr. Iordanova. “However, a growing number of studies demonstrate that even if we control for the fact that women live longer, they are still at higher risk than men to develop dementia, and we have only recently begun to examine the cause.” According to Dr. Iordanova, research suggests that vascular dysfunction and oxygen deficiencies may be major risk factors in AD for both men and women, however, evidence reveals that the pathways may be different and some susceptibilities may be significantly stronger in one sex. “The aging metabolic transitions in women have a specific bioenergetic profile with early mitochondrial dysfunction, a drop in vascular reactivity, and reduced oxygen availability,” said Dr. Iordanova. “This transitional stage makes women particularly vulnerable to vascular and metabolic assaults. It is important to note that the unique aspects of woman’s aging do not happen in isolation but interact with the genetic and environmental factors that are common for all humans.” Dr. Iordanova plans to use this award to compare metabolic and vascular health between male and female rat models and correlate the data with well-established hallmarks of AD such as amyloid plaques in brain tissues and blood vessels. Her laboratory, located at the Center for Bioengineering, develops multi-level imaging platforms to understand the neurovascular unit - a system that supports proper brain function through communication between neurons, which drives cerebral blood flow and local delivery of oxygen and glucose. “In patients with Alzheimer’s disease, a number of cellular events precede the onset of clinical symptoms, but the causal relationship between these events is still unclear,” said Dr. Iordanova. “For example, cerebral blood flow decreases, causing the delivery of nutrients and waste clearance to decrease; the neural responses asking for more oxygen and glucose from the blood flow also decrease; and amyloid accumulates in the blood vessels, while neurons degenerate and lose communication with each other.” Dr. Iordanova will use high field 9.4 Tesla magnetic resonance imaging at the Advanced Imaging Center to measure the sex-specific decline in cerebrovascular reactivity, cerebral blood flow, and oxidative and glucose metabolism in rodent models of AD. She will then use in vivo two photon microscopy to correlate these measures with the amyloid plaque accumulation in the blood vessels. She hopes that starting this data collection will spur other researchers to do the same and perhaps reveal biological differences between the sexes related to AD development. Dr. Iordanova is also the current recipient of a three-year, $175,000 Alzheimer’s Association Research Grant and an award from the Brain Institute to develop multimodal platforms for systems-level brain imaging in rodent models of dementia. “The use of knowledge about the sex differences in metabolic and vascular contributions to AD will benefit both men and women,” said Iordanova. “It will allow earlier diagnosis on a sex-specific timeline, improve personalized therapy development, and provide more accurate biomarkers for treatment monitoring.” ### 1 https://www.alz.org/media/HomeOffice/Facts%20and%20Figures/facts-and-figures.pdf

Gelsy Torres-Oviedo Receives Early Career Award from the Society for the Neural Control of Movement

Bioengineering

PITTSBURGH (March 19, 2019) … Gelsy Torres-Oviedo, assistant professor of bioengineering at the University of Pittsburgh, was awarded the Society for the Neural Control of Movement’s 2019 Early Career Award. She will be presented the award at the NCM Annual Meeting on April 23-27, 2019 in Toyama, Japan. NCM’s Early Career Award recognizes outstanding contributions by scientists who have significantly advanced the understanding of the neural control of movement within 10 years of receiving their doctoral degree. The recipient is chosen by NCM’s board and will have the opportunity to present a lecture at the annual meeting. Prof. Torres-Oviedo is the second recipient of this competitive award for junior faculty members, which receives close to 100 nominations annually. She leads the Sensorimotor Learning Laboratory in the Swanson School of Engineering where her research group investigates the ability of the human motor system to adapt walking patterns and learn new movements upon sustained changes in the environment. “My long-term research goals are to advance the current understanding of walking deficits post-stroke and develop treatments to improve their gait,” said Prof. Torres-Oviedo. “My approach has been to combine quantitative tools from engineering and experimental work based on post-stroke neurology.” She will present a talk titled, “Sensorimotor adaptation studies to advance neurorehabilitation after stroke,” where she will discuss her work related to the generalization of movements from trained to untrained situations. “My work is just an example of scientific efforts to address clinical problems through a combination of computational and laboratory-based studies,” said Prof. Torres-Oviedo. “I envision that my research will contribute to the progress of gait rehabilitation and ultimately improve the quality of life of patients and caregivers.” Prof. Torres-Oviedo will receive travel support to the meeting, accommodation at the conference hotel, complimentary conference registration, an engraved plaque, and a $500 award. “I am delighted that Prof. Torres-Oviedo’s work in the area of neural control of movement is being recognized by her colleagues,” said Sanjeev G. Shroff, Distinguished Professor and Gerald E. McGinnis Chair of Bioengineering. “Her work nicely complements the strengths we have at Pitt in systems neuroscience in general and neuro-prosthetics and rehabilitation neural engineering in particular.” ###

Dr. William Federspiel Receives the Carnegie Science Award for Life Sciences

Bioengineering

PITTSBURGH (March 19, 2019) … The University of Pittsburgh’s Dr. William Federspiel was selected as the recipient of the 2019 Carnegie Science Award for Life Sciences, one of 16 categories announced March 13 by the Carnegie Science Center. The award recognizes and honors scientific advances in new and innovative biomedical and life sciences endeavors that benefit the economy, health, or societal well-being of the region. Dr. Federspiel, the William Kepler Whiteford Professor of Bioengineering in the Swanson School of Engineering, directs the Medical Devices Lab in the McGowan Institute of Regenerative Medicine where researchers develop clinically significant devices for the treatment of pulmonary and cardiovascular ailments by utilizing engineering principles of fluid flow and mass transfer. In particular, Dr. Federspiel’s lab  have created next-generation artificial lung devices, including portable, wearable devices for adults and children suffering from lung disease. His research in artificial lung technology eventually led Dr. Federspiel to co-found ALung Technologies, a Pittsburgh-based medical device startup company that develops technology for treating respiratory failure. He serves as head of the scientific advisory board for the company, which is currently running clinical trials for their Hemolung® Respiratory Assist System (RAS), a dialysis-like alternative for or supplement to mechanical ventilation which removes carbon dioxide directly from the blood in patients with acute respiratory failure. “What motivates me about the research we do is that it all focuses ultimately on saving lives of patients, many of whom have no alternatives,” said Dr. Federspiel. In addition to his research, Dr. Federspiel also actively teaches and mentors: he has developed five courses in the Swanson School and has been the primary advisor for 15 PhD students and 15 master’s students. “Dr. Federspiel has been a major asset to our bioengineering program, both through his research and academic leadership” said Sanjeev Shroff, Distinguished Professor and Gerald E. McGinnis Chair of Bioengineering. “His innovative and highly translatable work with respiratory assist devices has the potential to affect the lives of thousands of patients suffering from lung disease.” Other awards and honors Dr. Federspiel has received include, Fellow of the Biomedical Engineering Society (BMES), Fellow of the American Institute for Medical and Biomedical Engineering (AIMBE), member of the American Society for Artificial Internal Organs (ASAIO), and in 2014 he received an honorable mention in the Startup Entrepreneur Award category from the Carnegie Science Awards. Dr. Federspiel and the rest of the awardees, including two winners and three honorable mentions from the Swanson School,  will be recognized at the 23rd Annual Carnegie Science Awards Celebration on May 10, 2019. ###

The ups and downs of sit-stand desks: Pitt bioengineer Dr. April Chambers compiles studies to examine the comprehensive benefits of the popular accessory

Bioengineering

PITTSBURGH (March 12, 2018) … Have a seat. No, wait! Stand. With researchers suggesting that “sitting is the new smoking,” sit-stand desks (SSD) have become a common tool to quell sedentary behavior in an office environment. As this furniture becomes ubiquitous, conflicting opinions have arisen on its effectiveness. The University of Pittsburgh’s Dr. April Chambers worked with collaborators to gather data from 53 studies and published a scoping review article detailing current information on the benefits of SSDs. “There has been a great deal of scientific research about sit-stand desks in the past few years, but we have only scratched the surface of this topic,” said Chambers, assistant professor of bioengineering in Pitt’s Swanson School of Engineering. “With my background in occupational injury prevention, I wanted to gather what we know so far and figure out the next steps for how can we use these desks to better benefit people in the workplace.” This work was done in collaboration with Dr. Nancy A. Baker, associate professor of occupational therapy at Tufts University, and Dr. Michelle M. Robertson, executive director for the Office Ergonomics Research Committee (OERC). The scoping review, published recently in Applied Ergonomics (DOI: 10.1016/j.apergo.2019.01.015), examines the effects of a sit-stand desk in the following domains: behavior, physiological, work performance, psychological, discomfort, and posture. “The study found only minimal impacts on any of those areas, the strongest being changes in behavior and discomfort,” said Baker. Their work showed that use of a SSD effectively got participants to sit less and stand more and that the device made users more comfortable at work. However, many frustrations with SSDs stem from the physiological outcomes. Early adopters were fed the idea that these desks would be the miracle cure for obesity, but users were not achieving the results they expected. According to the review, physiological effects were the most studied, but within that domain, there were no significant results with regards to obesity. “There are health benefits to using sit-stand desks, such as a small decrease in blood pressure or low back pain relief, but people simply are not yet burning enough calories to lose weight with these devices,” said Chambers. “Though these are mild benefits, certain populations might benefit greatly from even a small change in their health. In order to achieve positive outcomes with sit-stand desks, we need a better understanding of how to properly use them; like any other tool, you have to use it correctly to get the full benefits out of it.” There are many considerations to most effectively use a SSD, such as desk height, monitor height, amount of time standing, or the use of an anti-fatigue mat. Chambers believes that workplace setup and dosage are two factors that should be further studied. “There are basic ergonomic concepts that seem to be overlooked,” said Chambers. “Many workers receive sit-stand desks and start using them without direction. I think proper usage will differ from person to person, and as we gather more research, we will be better able to suggest dosage for a variety of workers.” Chambers noted that the current research is limited because many of studies were done with young and healthy subjects who were asked to use the desk for a week or month at most. Since some of the significant benefits are with cardiovascular health or muscle discomfort, it may be beneficial to perform additional studies with middle-aged or overweight workers. “There is still more to learn about sit-stand desks,” said Chambers. “The science is catching up so let’s use what we’ve studied in this area to advance the research and answer some of these pressing questions so that people can use sit-stand desks correctly and get the most benefit from them.” ###

Swanson School Undergrad Kaylene Stocking Wins the University’s Top Student Award for Scholarship

Bioengineering, Electrical & Computer, Student Profiles

Click here to view the PittWire Accolade. PITTSBURGH (February 28, 2019) … The 43rd annual Honors Convocation recognized the academic achievements of nearly 3,700 students and 478 faculty members, including the University’s highest awards for undergraduate students. The Emma W. Locke Award, given to a graduating senior in recognition of high scholarship, character and devotion to the ideals of the University of Pittsburgh, went to the Swanson School of Engineering’s Kaylene Stocking. “We are very proud of Kaylene’s accomplishments,” said Sanjeev Shroff, Distinguished Professor and Gerald E. McGinnis Chair of Bioengineering. “She has effectively leveraged Swanson School resources and her own ingenuity to achieve academic excellence within and outside of the classroom and make impactful contributions to the University community. We know she has a bright, successful future ahead!” Stocking is pursuing a bachelor’s degree in both bioengineering and computer engineering. Her research has led to three journal publications, two presentations and a Goldwater Scholarship honorable mention. She is also an undergraduate teaching assistant, an Honors College ambassador and member of the Pitt orchestra. For the past two years, she has been working in the BIONIC Lab led by Takashi D. Y. Kozai, assistant professor of bioengineering. Her work focuses on how researchers can improve the longevity of neural implant technology. "It has been an amazing experience to work with Kaylene,” said Kozai. “Her off-the-cuff insights into projects and scientific discussion as well as her simultaneous bird's-eye view perspective and understanding of how each individual piece of data fits into the larger story has been a major driving force in our research lab." Stocking plans to continue her education after graduating this spring. Regarding her time at Pitt, she said, “I'm so grateful for the many opportunities I've had thanks to the amazing Engineering and Honors College communities. I'd like to thank my professors, mentors, family, and friends for their encouragement and support over the last four years.” ###

Tenure/Tenure-Stream Faculty Position in Synthetic or Systems Biology

Bioengineering, Open Positions

The Department of Bioengineering at the University of Pittsburgh Swanson School of Engineering invites applications from accomplished individuals with a PhD or equivalent degree in bioengineering, biomedical engineering, or closely related disciplines for an open-rank, tenured/tenure-stream faculty position. We wish to recruit an individual with strong research accomplishments in Synthetic or Systems Biology, with preference given to research focus areas related to mammalian cellular engineering, immune engineering, or neural regeneration. It is expected that this individual will complement our current strengths in biomechanics, bioimaging, molecular, cellular, and systems engineering, medical product engineering, neural engineering, and tissue engineering and regenerative medicine. In addition, candidates must be committed to contributing to high quality education of a diverse student body at both the undergraduate  and graduate levels. Located in the Oakland section of Pittsburgh, the University of Pittsburgh is a top-five institution in terms of NIH funding, and provides a rich environment for interdisciplinary research, strengthened through its affiliation with the University of Pittsburgh Medical Center (UPMC). The Department of Bioengineering, consistently ranked among the top programs in the country, has outstanding research and educational programs, offering undergraduate (~270 students, sophomore-to-senior years) and graduate (~150 PhD or MD/PhD and ~50 MS students) degrees. The McGowan Institute for Regenerative Medicine (mirm.pitt.edu), Computational and Systems Biology (https://www.csb.pitt.edu/), the Vascular Medicine Institute (vmi.pitt.edu), the Brain Institute (braininstitute.pitt.edu), Starzl Transplantation Institute (http://www.stiresearch.health.pitt.edu/), and the Drug Discovery Institute (upddi.pitt.edu) offer many collaborative research opportunities. The Center for Medical Innovation (https://www.engineering.pitt.edu/CMI/), the Coulter Translational Partnership II Program (engineering.pitt.edu/coulter) and the Center for Commercial Applications of Healthcare Data (healthdataalliance.com/university-of-pittsburgh) provide biomedical innovation and translation opportunities. Interested individuals should send the following as a single, self-contained PDF attachment via email to bioeapp@pitt.edu (include “AY20 PITT BioE SynBio-SysBio” in the subject line): (1) cover letter, (2) complete CV (including funding record, if applicable), (3) research statement, (4) teaching statement, (5) three representative publications, and (6) names and complete contact information of at least four references. To ensure full consideration, applications must be received by June 30, 2019. However, applications will be reviewed as they are received. Early submission is highly encouraged. The Department of Bioengineering is fully committed to a diverse academic environment and places high priority on attracting female and underrepresented minority candidates. We strongly encourage candidates from these groups to apply for the position. The University affirms and actively promotes the rights of all individuals to equal opportunity in education and employment without regard to race, color, sex, national origin, age, religion, marital status, disability, veteran status, sexual orientation, gender identity, gender expression, or any other protected class.

Pitt Bioengineers Create Ultrasmall, Light-Activated Electrode for Neural Stimulation

Bioengineering

PITTSBURGH (February 15, 2019) … Neural stimulation is a developing technology that has beneficial therapeutic effects in neurological disorders, such as Parkinson’s disease. While many advancements have been made, the implanted devices deteriorate over time and cause scarring in neural tissue. In a recently published paper, the University of Pittsburgh’s Takashi D. Y. Kozai detailed a less invasive method of stimulation that would use an untethered ultrasmall electrode activated by light, a technique that may mitigate damage done by current methods. “Typically with neural stimulation, in order to maintain the connection between mind and machine, there is a transcutaneous cable from the implanted electrode inside of the brain to a controller outside of the body,” said Kozai, an assistant professor of bioengineering in Pitt’s Swanson School of Engineering. “Movement of the brain or this tether leads to inflammation, scarring, and other negative side effects. We hope to reduce some of the damage by replacing this large cable with long wavelength light and an ultrasmall, untethered electrode.” Kaylene Stocking, a senior bioengineering and computer engineering student, was first author on the paper titled, “Intracortical neural stimulation with untethered, ultrasmall carbon fiber electrodes mediated by the photoelectric effect” (DOI: 10.1109/TBME.2018.2889832). She works with Kozai’s group - the Bionic Lab - to investigate how researchers can improve the longevity of neural implant technology. This work was done in collaboration with Alberto Vasquez, research associate professor of radiology and bioengineering at Pitt. The photoelectric effect is when a particle of light, or a photon, hits an object and causes a local change in the electrical potential. Kozai’s group discovered its advantages while performing other imaging research. Based on Einstein's 1905 publication on this effect, they expected to see electrical photocurrents only at ultraviolet wavelengths (high energy photons), but they experienced something different. “When the photoelectric effect contaminated our electrophysiological recording while imaging with a near-infrared laser (low energy photons), we were a little surprised,” explained Kozai. “It turned out that the original equation had to be modified in order to explain this outcome. We tried numerous strategies to eliminate this photoelectric artifact, but were unsuccessful in each attempt, so we turned the ‘bug’ into a ‘feature.’” “Our group decided to use this feature of the photoelectric effect to our advantage in neural stimulation,” said Stocking. “We used the change in electrical potential with a near-infrared laser to activate an untethered electrode in the brain.” The lab created a carbon fiber implant that is 7-8 microns in diameter, or roughly the size of a neuron (17-27 microns), and Stocking simulated their method on a phantom brain using a two-photon microscope. She measured the properties and analyzed the effects to see if the electrical potential from the photoelectric effect stimulated the cells in a way similar to traditional neural stimulation. “We discovered that photostimulation is effective,” said Stocking. “Temperature increases were not significant, which lowers the chance of heat damage, and activated cells were closer to the electrode than in electrical stimulation under similar conditions, which indicates increased spatial precision.” The lab recently showed how electrical stimulation frequency can activate different populations of neurons. “What we didn’t expect to see was that this photoelectric method of stimulation allows us to stimulate a different and more discrete population of neurons than could be achieved with electrical stimulation.” said Kozai, “This gives researchers another tool in their toolbox to explore neural circuits in the nervous system. “We’ve had numerous critics who did not have faith in the mathematical modifications that were made to Einstein’s original photoelectric equation, but we believed in the approach and even filed a patent application” (patent pending:US20170326381A1), said Kozai. “This is a testament to Kaylene’s hard work and diligence to take a theory and turn it into a well-controlled validation of the technology.” Kozai’s group is currently looking further into other opportunities to advance this technology, including reaching deeper tissue and wireless drug delivery. Stocking anticipates  graduating in April 2019 and plans to pursue a doctoral degree. She said, “The University of Pittsburgh has amazing resources that have allowed me to gain meaningful research experience as an undergraduate, and I’m grateful to Dr. Kozai and the Department of Bioengineering for giving me the opportunity to do impactful work.” ###

Making a Mark on Cardiovascular Disease Detection

Bioengineering

PITTSBURGH (February 12, 2019) … According to the American Heart Association, cardiovascular disease (CVD) remains the number one cause of death in the United States.1 Conditions for cardiomyopathy, a heart muscle disease leading to heart failure, are clinically silent until serious complications arise, and current diagnostic tools are unreliable, time consuming, and expensive. Moni K. Datta, assistant professor of bioengineering at the University of Pittsburgh Swanson School of Engineering, received a $300,000 award from the Department of Defense to develop a quicker, simpler, and more reliable diagnostic technology related to cardiomyopathy so that the signs of disease can be spotted and treated earlier. One method currently applied to cardiovascular disease diagnosis is biochemical marker testing, using only bodily fluids or tissues to search for substances that signal disease or other abnormalities. The goal of this project, “Novel Aptamer-Based Biosensor Platforms for Detection of Cardiomyopathy Conditions,” is to create a tool that more efficiently senses and detects various essential cardiac biomarkers in the bloodstream. This work has previously received funding from the Department of Bioengineering’s Coulter Program as well as the Clinical Translational Science Institute (CTSI) Translational Research Pilot Award. Prashant N. Kumta, Edward R. Weidlein Chair and Distinguished Professor of bioengineering, chemical and petroleum engineering, mechanical engineering and materials science, and professor of oral biology in the School of Dental Medicine, is co-investigator on the project with Robert L. Kormas, Brack G. Hattler Professor of Cardiothoracic Surgery at the University of Pittsburgh Medical Center. Datta said, “Dr. Kumta has extensive experience related to materials functionalization and generation of materials platforms for detection and sensing of biological markers while Dr. Robert Kormas is a renowned cardiologist and an expert in understanding the cardiac biomarkers connected to various cardiovascular diseases.” The group will develop a portable biosensor specific to the cardiac biomarkers using only a few drops of blood to detect and provide the levels within minutes. “The design will include a vertical array of metallic wires functionalized with biological sensing agents, namely the aptamer specific to binding the relevant cardiac biomarkers in the blood,” said Datta. “The resulting platform will measure the change in overall resistance due to the binding of the specific cardiac biomarker to the sensing element. The developed biosensors are extremely sensitive to the resistance changes and as a result, will accurately measure the levels of relevant cardiac markers in the blood, thereby serving as an effective measuring device.” Current biochemical marker assays in hospitals and clinics are benchtop machines that lack portability and require expensive instrumentation and training. Datta’s design will be optimized for precision, reliability, and portability, making biochemical marker testing more accessible in hospitals, emergency room settings, ambulances, and perhaps even at home. “This device will allow patients and clinicians to screen for and circumvent cardiovascular diseases at early stages, thus reducing the cardiovascular disease risk and eventual healthcare costs,” said Datta. “Development of this biosensor will create a simple, inexpensive, and efficient point-of-contact device. We hope to eventually make this versatile technology useful for detection and monitoring disease conditions outside of cardiovascular disease states.” ### 1 According to the AHA… https://www.heart.org/-/media/data-import/downloadables/heart-disease-and-stroke-statistics-2018---at-a-glance-ucm_498848.pdf

Pitt’s Center for Medical Innovation awards five novel biomedical projects with $60,000 in Round-2 2018 Pilot Funding

All SSoE News, Bioengineering

PITTSBURGH (January 29, 2019) … The University of Pittsburgh’s Center for Medical Innovation (CMI) awarded grants totaling $60,000 to three research groups through its 2018 Round-2 Pilot Funding Program for Early Stage Medical Technology Research and Development. The latest funding proposals include a new drug-eluting contact lens for treatment of dry eye disease, a new method of measuring ocular changes in glaucoma, and a new instrument for management of ketogenic diets. CMI, a University Center housed in Pitt’s Swanson School of Engineering (SSOE), supports applied technology projects in the early stages of development with “kickstart” funding toward the goal of transitioning the research to clinical adoption. Proposals are evaluated on the basis of scientific merit, technical and clinical relevance, potential health care impact and significance, experience of the investigators, and potential in obtaining further financial investment to translate the particular solution to healthcare. This is our eighth year of pilot funding, and our leadership team could not be more excited with the breadth and depth of this round’s awardees,” said Alan D. Hirschman, PhD, CMI Executive Director. “This early-stage interdisciplinary research helps to develop highly specific biomedical technologies through a proven strategy of linking UPMC’s clinicians and surgeons with the Swanson School’s engineering faculty.”AWARD 1:  “Polyelectrolyte Multilayer Coating for Delivery of IL-4 from Contact Lenses for Dry Eye Disease” For the development of a drug-eluting contact lens for treatment of chronic “dry eye” disease.Bryan Brown, PhD, Assistant Professor, Depts. of Bioengineering, Obstetrics, Gynecology, and Reproductive Sciences; McGowan Institute for Regenerative MedicineVishal Jhanji, MD, FRCSG, FRCOphth, Professor of Ophthalmology, Cornea, External Eye Diseases and Refractive Surgery Services, UPMC Eye Center Mangesh Kulkarni, MD, PhD, Research Assistant Professor, McGowan Institute for Regenerative Medicine and department of Bioengineering AWARD 2: “On the quantitative analysis of a new tonometer to manage/prevent glaucoma” For the development of a novel pulse wave device for measurement of ocular tissue characteristics in the detection and treatment of glaucoma.Piervincenzo Rizzo, PhD, Professor, Department of Civil and Environmental Engineering, University of PittsburghIan A. Sigal, PhD, Assistant Professor, Department of Ophthalmology, University of Pittsburgh Medical Center, Eye & Ear InstituteIan Conner, PhD, MD, Assistant Professor of Ophthalmology, Department of Ophthalmology, University of Pittsburgh AWARD 3: “Acetone Breathalyzer for Monitoring the Ketogenic State” For the development of a cost-effective, rapid acetone “breath-alayzer” for clinical and consumer usage in ketogenic diets.Sung Kwon Cho, PhD, Department of Mechanical Engineering & Materials Science, Swanson School of EngineeringDavid Rometo, MD, Div of Endocrinology and Metabolism, U of Pittsburgh Medical CenterDavid Finegold, MD,  Department of Human Genetics, Graduate School of Public HealthAlex Star, PhD,  Department of Chemistry, Dietrich School of Arts and Science ### About the University of Pittsburgh Center for Medical InnovationThe Center for Medical Innovation is a collaboration among the Swanson School of Engineering, the Clinical and Translational Science Institute (CTSI), the Innovation Institute, and the Coulter Translational Research Partnership II (CTRP). CMI was established in 2011 to promote the application and development of innovative biomedical technologies to clinical problems; to educate the next generation of innovators in cooperation with the schools of Engineering, Health Sciences, Business, and Law; and to facilitate the translation of innovative biomedical technologies into marketable products and services. Over 60 early-stage projects have been supported by CMI with a total investment of over $1.2 million since inception. Nine companies have been formed to commercialize these early stage University of Pittsburgh technologies.
Alan Hirschman, PhD Executive Director, CMI

Changing Frequencies: Pitt Bioengineers Look Deeper Into How Electrical Stimulation Activates Neurons

Bioengineering

PITTSBURGH (January 7, 2019) … Electrical stimulation of the brain is common practice in neuroscience research and is an increasingly common and effective clinical therapy for a variety of neurological disorders. However, there is limited understanding of why this treatment works at the neural level.  A paper published by Takashi D. Y. Kozai, assistant professor of bioengineering at the University of Pittsburgh Swanson School of Engineering, addresses gaps in knowledge over the activation and inactivation of neural elements that affect the desired responses to neuromodulation. The article, “Calcium activation of cortical neurons by continuous electrical stimulation: Frequency dependence, temporal fidelity, and activation density” (DOI: 10.1002/jnr.24370), was published in the Journal of Neuroscience Research. Co-investigator is Kip Ludwig, associate professor of biomedical engineering at the University of Wisconsin-Madison. For this study, Kozai’s group - the BIONIC Lab - used in vivo two-photon microscopy to capture neuronal calcium activity in the somatosensory cortex during 30 seconds of continuous electrical stimulation at varying frequencies. They imaged the population of neurons surrounding the implanted electrode and discovered that frequency played a role in neural activation - a finding that conflicted with earlier studies. “Electrical stimulation has a large number of parameters that can be used to activate neurons, such as amplitude, pulsewidth, waveform shapes, and frequency,” explained Kozai. “This makes it difficult to compare studies because different stimulation parameters are used in other studies. Based on the parameters that were previously employed, it was thought that activation occurs in a sphere centered around the electrode where neurons near the electrode would activate more than neurons far from the electrode. “Recent research, however, shows that stimulation mostly activates distant neurons whose axons are very close to the electrode by transmitting action potentials backward to the neuron cell body,” he continued. “We demonstrate that both of these things can be true depending on stimulation frequency and duration.” According to Kozai, the fact that researchers can use varying stimulation parameters to activate different neurons in the same location has huge implications in basic science research. The findings will allow them to activate different neural circuits with the same implant to elicit different behaviors. Beyond its research applications, Kozai believes that this knowledge may also help in clinical settings. “Empirical evidence in the field suggests that frequency plays a role in deep brain stimulation, but the why and how have puzzled scientists since the beginning,” said Kozai. “This research is a first glimpse into understanding the mechanisms underlying the role of frequency in clinical therapies. In the long-term, this research could also give insight on how to activate distinct glial and vascular populations, which could have a prolonged impact on behavior, attention, and tissue regeneration.” Kozai believes that more research needs to be done to understand neuronal activation properties and hopes that this work will lead to new tools in neuroscience and improved neuromodulation therapy by explaining why electrical stimulation produces its effective responses. ###